August 10, 2020

Volume X, Number 223

August 07, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
28
Apr
Renewing the Debate Over Renewables Poyner Spruill LLP
18
Apr
Could Hydrofracking Cause Cancer? Risk and Insurance Management Society, Inc. (RIMS)
18
Apr
USDA Announces Funding for Blender Pumps Michael Best & Friedrich LLP
13
Apr
Myriad Oral Arguments – Section 101 vs. Chemistry 101? Schwegman, Lundberg & Woessner, P.A.
12
Apr
U.S. Department of Energy and Qatar Sign Agreement to Strengthen Cooperation on Clean Energy U.S. Department of Energy
9
Apr
Climate Facts and Fancy: From God to Cows, Facts and Falsehoods Accompany Global Warming Votes Center for Public Integrity
5
Apr
Federal Court Hears Myriad Gene Case This Morning Schwegman, Lundberg & Woessner, P.A.
5
Apr
Supreme Court Determines Materiality Standard for Adverse Event Reports Vedder Price
2
Apr
One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe Schwegman, Lundberg & Woessner, P.A.
1
Apr
Banning Stem Cell Research — Or Cloning? Or Both? Schwegman, Lundberg & Woessner, P.A.
1
Apr
Department of Energy Launches "America's Next Top Energy Innovator" U.S. Department of Energy
29
Mar
A MATRIXX Revolution, Part II: Supreme Court affirms Ninth Circuit's holding that Life Science Companies Cannot Rely On a Statistical Significance Standard When Deciding Whether Adverse Event Reports are Material for the Purpose of Securities Disclosures Sheppard, Mullin, Richter & Hampton LLP
28
Mar
Cleantech Patents: When is Trade Secret the Right Protection? Michael Best & Friedrich LLP
27
Mar
U.S. Department of Energy Releases Radiation Monitoring Data from Fukushima Area U.S. Department of Energy
27
Mar
Tips To Get A New Market Tax Credit Commitment Michael Best & Friedrich LLP
18
Mar
EPA Redefines “Solid Waste” to Incentivize Creative Fuel Technology: Garbage to Gold Taft Stettinius & Hollister LLP
17
Mar
While Touting Green Power, Democrats Arrange Duke Energy Backup Loan Center for Public Integrity
14
Mar
Energy Department Announces New Advance in Biofuel Technology U.S. Department of Energy
12
Mar
The USDA Accepting Applications for Biobased Product Label Michael Best & Friedrich LLP
9
Mar
EPA Postpones Deadline for Reporting 2010 GHG Emissions Greenberg Traurig, LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS